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H I G H L I G H T S
 Lead exposure is measured by invasive blood sampling. A non-invasive alternative is desirable.
 We determine lead in blood and saliva in 105 UK workers, presenting a new method for saliva analysis.
 Blood–saliva correlation improves at higher exposures; unchanged by history, smoking or age.
 StatSure device is effective for high levels. Contamination hinders lower-level measurements.
 Saliva lead may be effective as a surrogate for blood lead only in highly-exposed populations.
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A B S T R A C T
Introduction: Whole blood is the established matrix for biological monitoring of inorganic lead; however
blood sampling is an invasive procedure. Saliva offers a potential non-invasive alternative. This study
determines lead in whole blood and saliva. A novel method for saliva sampling and preparation is
presented.
Methods: Paired blood and saliva samples were obtained from 105 occupationally exposed UK workers.
Saliva was collected using a StatSure sampling device, and a nitric acid digestion step was incorporated.
The utility of the device for this application was evaluated. Whole blood was obtained by venepuncture.
Analyses were carried out by ICP-MS.
Results: The limit of detection for lead in saliva was 0.011 mg/L. Mean blank-corrected recovery from
10 mg/L spiked saliva was 65.9%. The mean result from blank saliva extracted through the StatSure device
was 2.86 mg/L, compared to 0.38 mg/L by direct analysis. For the paired samples, median blood lead was
6.00 mg/dL and median saliva lead was 17.1 mg/L. Pearson’s correlation coefﬁcient for saliva lead versus
blood lead was 0.457 (95% C.I. 0.291–0.596).
Conclusions: ICP-MS analysis allows sensitive determination of lead in saliva with low limits of detection.
The StatSure device is effective for high occupational exposures, but contamination from the device could
confound lower-level measurements. Saliva would only be effective as a surrogate for whole blood for
highly-exposed populations, although with further work it may have applications as a biomarker of
recent exposure.
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nc-nd/3.0/).1. Introduction
Workers in a wide range of industries are at risk of occupational
exposure to lead. Although the adverse effects of acute lead
poisoning are well-known, most incidences of lead toxicity occur
through the accumulation of lead in the body by repeated
exposures to small amounts (Thaweboon et al., 2005). Toxic
effects of repeated low-level lead exposures include hypertension,ess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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(Goyer,1993). Lead is also classiﬁed by the International Agency for
Research on Cancer (IARC) as a class 2B carcinogen, indicating that
“the agent is possibly carcinogenic to humans” (IARC, 2013).
However, the major risk of lead exposure is toxicity to the nervous
system, with the most susceptible populations being children,
infants and the foetus (Goyer and Clarkson, 2001).
Lead may be absorbed into the body by several different
pathways. In the UK, biological monitoring for lead is mandatory
under the Control of Lead at Work Regulations (2002) where a
worker’s risk of lead exposure is considered signiﬁcant by
inhalation, ingestion or dermal absorption (HSC/HSE 2002). Whole
blood is currently the matrix most commonly used for the
determination of inorganic lead exposure and has been used as
such for over ﬁfty years (Agency for Toxic Substances and Disease
Registry, 2007). However, blood sampling is an invasive procedure.
Sample collection requires a qualiﬁed phlebotomist, and therefore
incurs expense. The procedure also causes discomfort, which may
be a source of stress to workers participating in monitoring. A non-
invasive alternative would therefore be desirable.
As well as occupational exposures, lead exposure from
environmental sources is increasingly a matter of concern,
especially involving populations living in low-income urban
communities (Nriagu et al., 2006). A cheap, simple, non-invasive
sampling technique would facilitate much more extensive studies
of such environmental exposures.
Several studies have explored saliva as an alternative matrix
for the biological monitoring of lead (Koh et al., 2003; Nriagu
et al., 2006; Barbosa et al., 2006; Costa de Almeida et al., 2009).
The use of saliva would have several potential advantages: its
collection is non-invasive and therefore there are no concerns
over discomfort to participants; collection is straightforward and
cheap to carry out; sample storage and transport arrangements
are less complex than those for blood; and in addition the ethical
approval for sampling is more easily obtained (Nriagu et al., 2006;
Morton et al., 2014).
It is thought that the lead content of saliva may be related to the
unbound fraction in the plasma (Nriagu et al., 2006), and as the
plasma composition closely reﬂects that of the extracellular ﬂuid,
measuring salivary lead may therefore indicate the level of
exposure to which most bodily cells are subjected (Costa de
Almeida et al., 2009). However, using saliva does present some
problems, particularly in the collection and preparation of the
sample: the ﬂow and ion content of saliva can vary signiﬁcantly
throughout the day; whole saliva may contain other substances
such as food debris, bacteria and epithelial cells; and hand-to-
mouth behaviour prior to sample collection could cause sample
contamination (Barbosa et al., 2006). There is also no widely
agreed method to adjust for how dilute/concentrated the saliva
collected is (such as creatinine-correction for the analysis of urine).Table 1
Descriptive statistics of the sample cohort.
All samples History
1 2 
Number of paired samples 105 27 
Number of smokers 53 11 
Number of non-smokers 52 16 
Age range (years) 18–65 19–65 19
Mean age (years) 37 40 
Median age (years) 35 44 
Mean Da (mg/dl) 0.63 0.07 
Standard deviation Da (mg/dl) 9.49 0.79 
Median Da (mg/dl) 1.00 0.00 
Da interquartile range (mg/dl) 2.00–1.00 1.00–0.89 
a D = the difference between the result of the study Pb(B) value and the mean of theThe literature does not present a standard method for the
collection and preparation of saliva samples. The use of stimulants
to increase saliva ﬂow, collection of whole saliva versus particular
components of saliva, the choice of sampling device and the
treatment of the saliva before analysis have been approached very
differently by different authors (Koh et al., 2003; Nriagu et al., 2003
Barbosa et al., 2006; Costa de Almeida et al., 2009; Thaweboon
et al., 2005; Morton et al., 2014).
Past studies have also produced very different results when
comparing lead levels in blood and saliva. The saliva lead: blood
lead ratio has varied from <1% (Barbosa et al., 2006) up to 271%
P’an AYS, 1981. The correlation reported between saliva lead and
blood lead has also varied: P’an AYS, 1981 and Morton et al. (2014)
reported good correlations (r = 0.80 and r = 0.69 respectively)
between log(blood lead) and log(saliva lead), Koh et al. (2003)
reported a weaker correlation (r = 0.41) between log(saliva lead)
and blood lead, whereas others have reported poorer correlations
(Barbosa et al., 2006; Nriagu et al., 2006; Thaweboon et al., 2005).
In this study, paired samples of whole blood and saliva were
collected from UK workers occupationally exposed to inorganic
lead, as part of their routine biological monitoring schedule. The
authors present a novel method for the collection and preparation
of saliva for analysis, using a StatSure (StatSure Diagnostics
Systems, Inc., New York, USA) saliva collection device and
incorporating a nitric acid digestion preparation step, prior to
dilution with an acid diluent. Whole blood was collected by
venepuncture and diluted with an alkaline diluent. Analyses of
both matrices for lead were carried out by inductively-coupled
plasma mass spectrometry (ICP-MS).
The recovery of lead from a 10 mg/L spiked saliva sample using
the StatSure device was evaluated, and components of the device
tested individually for any lead emanating from them. The
correlation between blood lead and saliva lead measurements in
an occupationally-exposed cohort was calculated, and multiple
regression analyses carried out to explore whether this relation-
ship was affected by age, smoking status or the history of previous
lead exposure.
2. Methods
2.1. Study cohort
This study determines lead levels in paired blood and saliva
samples from a cohort of 105 UK workers routinely monitored for
occupational exposure to inorganic lead. The study was approved
by the National Research Ethics Service Committee East Midlands
– Nottingham 1 (12/EM/0217). Consenting workers were asked to
provide a saliva sample at the same time as their routine blood
sample. Descriptive statistics of the sample cohort are provided in
Table 1.3 Fluctuating history No history
42 44 21 40
19 19 10 24
23 25 11 16
–65 19–65 21–55 18–58
42 42 33 32
43 43 33 30
0.53 0.50 3.01 N/A
1.19 1.34 16.60 N/A
0.80 0.80 4.00 N/A
1.50–0.00 1.53–0.19 7.71–11.00 N/A
 historical Pb(B) observations.
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Saliva samples were collected using the StatSure sampling device
(Fig. 1). The mouth was not rinsed prior to sampling. The collector
paddle was positioned under the tongue until the indicator at the
opposite end turned blue (as per the manufacturer’s guidelines). This
indicates that a volume of at least 1 mL of saliva has been collected by
the device. The collector was then removed from the mouth and
inserted into the tube, so that the paddle end was immersed in the
buffer solution. The cap was placed over the top of the collector stem
and pushed to close. The tube was then gently shaken to mix the
saturated collector with the buffer.
Whole blood samples were collected by venepuncture, in an
ethylenediaminetetraacetic acid (EDTA) coated Vacutainer (BD,
Oxford, UK).
The paired samples were transported immediately to the
Health and Safety Laboratory, Buxton (HSL). Upon receipt the blood
samples were refrigerated and analysed within 5 working days.
The saliva samples were stored at 20 C and analysed as a single
batch once all samples had been received. The devices were stored
intact (i.e. with the sampling paddle immersed in the buffer
solution).
2.3. Analytical methods
2.3.1. Analysis of blood samples
The blood samples were analysed for lead according to HSL’s
standard operating procedure. Whole blood was diluted 1 in
50 with an alkaline diluent (1 g/L EDTA (Fisher Scientiﬁc, Lough-
borough, UK), 0.1% v/v Triton X-100 (Fisher Scientiﬁc, Lough-
borough, UK), 1% v/v ammonia (Romil Ltd., Cambridge, UK) and
80 mg/L platinum (VWR Standards, Lutterworth, Leicestershire,
UK) as an internal standard. Standard solutions were prepared
from a 1000 mg/L lead standard solution (VWR Standards, Lutter-
worth, Leicestershire, UK). The ﬁnal calibration range was 10–
80 mg/dL.
External certiﬁed reference materials (CRM) used were
Lyphochek Whole Blood Metals Control levels 1 and 3 (Bio-Rad
Laboratories Ltd., Hemel Hempstead, UK) and were analysed at the
start and end of every run. A matrix-matched 40 mg/dL standard
check was run at the start, end and after every 10 samples to
monitor drift over the course of the run. If drift exceeded 10%, the
run was repeated.
The method is accredited by the United Kingdom Accreditation
Service (UKAS) and routine external quality assurance schemes are
successfully participated in (United Kingdom National External
Quality Assessment Service (UK-NEQAS) monthly and the German
External Quality Assessment Scheme for analyses in biological
materials (G-EQUAS) annually).Fig. 1. StatSure saliva sampling device – collection paddle (above) and tube
containing buffer solution (below).2.3.2. Analysis of saliva samples
The sampling devices were thawed at room temperature,
placed on rollers for 1 h and then vortex-mixed for 10 s each. The
paddle was then removed and discarded. In screw-cap 5 mL
polypropylene tubes (Sarstedt Ltd., Leicester, UK) 0.15 mL of the
saliva/buffer mixture was added to 0.15 mL concentrated nitric acid
(Romil Ltd., Cambridge, UK). The tubes were capped, vortex-mixed
and heated for 1 h at 100 C. The tubes were cooled and vortex-
mixed. The acid-digested sample was then diluted 1 in 10: each
sample contained 0.25 mL of the digest, 0.75 mL ultrapure water
(Millipore, Watford, UK) and 1.50 mL acid diluent (1% v/v conc.
nitric acid, 10 mg/L platinum as internal standard). Standard
solutions were prepared in 5% v/v nitric acid, from a 1000 mg/L
lead standard solution. The ﬁnal calibration range was 0.05–10 mg/
L. A 0.5 mg/L standard was run at the beginning and end, and after
every 10 samples, in order to check for drift over the course of the
run.
Quality control (QC) samples were prepared using blank saliva
(Innovative Research, Novi, MI, USA) which was analysed both as a
blank, and spiked with 10 mg/L lead. For “Device” QCs, 1 mL of
saliva was sampled from a plastic beaker using the StatSure
sampling device. The device was stored overnight at 20 C and
then prepared as the samples were. For “Fresh” QCs, 1 mL spiked
saliva was added to 1 mL ultrapure water (to replicate the volume
of buffer in the device) and mixed. This mixture was then analysed
as the device contents were. “Fresh” and “Device” QCs (blank and
10 mg/L spike) were analysed at the beginning and end of the
analysis and after every 20 samples. An external CRM, Lyphochek
Urine Metals Control level 1 (no saliva CRM material is
commercially available), lot 69151 (Bio-Rad Laboratories Ltd.,
Hemel Hempstead, UK) was prepared as the “Fresh” QC was, and
also analysed at the beginning and end of the analysis and after
every 20 samples.
2.3.3. ICP-MS analyses
The diluted blood and saliva samples were analysed using a
Thermo X7 Series 2 ICP-MS instrument (Thermo-Fisher Scientiﬁc,
Hemel Hempstead, UK). The instrument was tuned on a daily basis
to ensure optimisation. The instrument was set up with direct
nebulisation in normal mode with optimised conditions. Extrac-
tion voltage was typically – 100 V, Rf Power 1400 W, focus voltage
12.0 V and nebuliser gas ﬂow rate (using a Burgener Miramist
nebuliser (Burgener Research International, Kingston-upon-
Thames, UK)) 0.83 L/min. Dwell times were 50 ms for 208Pb for
blood analysis and 100 ms for 208Pb for saliva analysis, both
methods had a dwell of 10 ms for 195Pt. 3 replicates per sample
were carried out. For blood analysis there were 100 sweeps per
replicate, for saliva analysis, 50 sweeps per replicate.
2.4. Additional testing of sampling devices
2.4.1. Blank saliva
An additional investigation was carried out, to investigate
whether any contamination of the sample could occur from the
StatSure sampling device, and if so, whether the freezing/thawing
process had any effect.
Four sample types were prepared using blank saliva:
 A) 1 mL of refrigerated blank saliva – prepared as the “Fresh” QC
above.
 B) 1 mL of frozen and thawed blank saliva – prepared as the
“Fresh” QC above.
 C) 1 mL of refrigerated blank saliva – sampled using device; ﬁlled
device refrigerated overnight before analysis.
 D) 1 mL of refrigerated blank saliva – sampled using device; ﬁlled
device frozen overnight before analysis.
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same ICP-MS method as speciﬁed above.
2.4.2. Comparison of device components
The individual components of the sampling device were also
investigated, in order to elucidate from which part of the device
any possible contamination originated. Samples were prepared
from the buffer contained within the device, the paddle with which
the saliva is collected, and the outer tube. From each device, the
buffer was decanted into a 5 mL screw-cap polypropylene tube.
The outer tube component was then rinsed thoroughly with
ultrapure water and dried, before adding 2 mL ultrapure water and
capping the tube. The head of the paddle component was cut from
its stick and placed in a screw-cap 5 mL polypropylene tube. All
tubes were vortex-mixed for 10 s and then rolled for 1 h before
being stored overnight at 20 C. The samples were then thawed at
room-temperature, rolled for a further hour and vortex-mixed for a
further 10 s. The contents of each tube were then diluted 1 in
10 and analysed by ICP-MS as per the method speciﬁed above. Five
of each sample type were analysed.
2.5. Statistical analyses:
2.5.1. Categorisation of exposure history
In order to ascertain whether a worker with a “steady” history of
lead exposure would produce differing results to one whose lead
exposure had ﬂuctuated, it was necessary to quantify the degree to
which each worker’s historical exposure had ﬂuctuated. Over 90%
of the lead content of whole blood is contained in the erythrocytes
(Goyer, 2001). The average survival time of erythrocytes in the
bloodstream is 120 days (Dessypris, 1999). To account for this, the
mean of all blood lead values acquired since January 2009, and
recorded 120 days prior to the measurement of the study sample,
was calculated for each individual. The difference between the
result of the study blood lead value and the mean of the historical
observations (D) was then calculated. The median D was 1 mg/dL,
and the 25th and 75th percentiles 2 mg/dL and +1 mg/dL
respectively. However, the presence of a small number of large
D values produced an overall standard deviation of 9.49 mg/dL. It
was decided to categorise the samples for their exposure history
according to the magnitude of D. History “1” included all samples
where D   1 mg/dL; history “2” all samples where D   2 mg/dL;
history “3” all samples where D   3 mg/dL. Samples where D
>  3 mg/dL were categorised as “ﬂuctuating history”. Samples
with no blood lead values recorded 120 days prior to the
measurement of the study sample were categorised as “no sample
history”.
2.5.2. Regression analysis
Neither the blood lead nor the salivary lead data were normally
distributed, with the salivary lead data more skewed than the
blood lead data. Both datasets could be much more closelyTable 2
Summary statistics for lead levels in blood and saliva samples.
All samples History 
1 2 
Blood Pb Number of samples 105 27 42 
Mean (mg/dl) 8.34 5.59 5.40 
Median (mg/dl) 6.00 4.00 4.00 
Interquartile range (mg/dl) 3.00–11.00 3.00–6.50 3.00–6.00 
Sandard deviation (mg/dl) 7.99 4.16 3.72 
–
Saliva Pb Mean (mg/l) 40.2 19.8 27.8 
Median (mg/l) 17.1 15.5 15.7 
Interquartile range (mg/l) 11.5–43.9 11.3–23.8 10.4–29.1 
Standard deviation (mg/l) 56.1 14.2 31.9 approximated to a log-normal distribution; therefore the relation-
ship between log(saliva lead) and log(blood lead) was investigated.
Log(saliva lead) was plotted against log(blood lead) and the
Pearson’s correlation coefﬁcient (r) was calculated, for the entire
dataset and for the various history categories.
Multiple regression analyses were also carried out to investigate
whether smoking status or the age of the participant had any effect
on the saliva or blood lead levels, or on the relationship between the
two.
3. Results
3.1. Analytical performance
For the blood lead analysis, all CRM results were within the
certiﬁed range. Values obtained for the CRMs were as follows: level
1 lot 36741 (certiﬁed range 9.39–14.1 mg/dL): n = 91 mean 11.1 mg/
dL, standard deviation (SD) 0.63 mg/dL; level 3 lot 36743 (certiﬁed
range 43.7–65.5 mg/dL): n = 91, mean 52.5 mg/dL, SD 2.81 mg/dL.
The limit of detection (LOD) for the saliva analysis for the study
was 0.011 mg/L, based on the mean of all the blank samples, plus
three times the standard deviation of the mean (McNaught and
Wilkinson, 1997). All results were greater than the LOD and
therefore no non-detects were observed. A urine-based CRM
(Lyphochek Urine Metals Control level 1, lot 69151) was analysed
with the saliva samples. All results from this CRM fell within the
acceptable range (8.82–13.2 mg/L).
The results of the prepared QC saliva samples were used to
calculate percentage recoveries for the 10 mg/L spiked sample,
corrected for the lead level present in the blank, for both the
“Fresh” and “Device” QCs. For the “Fresh” QCs, recovery of 107.7%
was observed. For the “device” QCs, recovery was 65.9%.
3.2. Summary statistics
Descriptive statistics of the sample cohort are provided in
Table 1. The cohort comprised 105 paired blood and saliva samples.
All participants were male (this was not an intentional discrimi-
nation by the authors, but due to the presence of very few female
workers in the industries studied). There were 53 samples
provided by smokers and 52 by non-smokers. The age range of
participants was 18–65 years, with a mean age of 37 years old and a
median age of 35 years old. Forty of the individuals sampled were
categorised as having “no sample history”. History category 1
(D =  1 mg/dL) included 27 samples; category 2 (D =  2 mg/dL)
included 42 samples; and category 3 (D = 3 mg/dL) included
44 samples. The remaining 21 samples had D >  3 mg/dL and were
classiﬁed as “ﬂuctuating history”.
Summary statistics of the lead levels observed in both the
blood and in the saliva samples are presented in Table 2. There
were no signiﬁcant differences in blood lead values between the
history categories 1–3 (mean: 5.59 mg/dL, 5.40 mg/dL andSmoking status
3 Fluctuating history No history Smoker Non-smoker
44 21 40 53 52
5.91 17.62 6.15 7.94 8.75
4.00 15.00 5.00 6.00 5.50
3.00–7.00 10.00–18.00 2.75–7.25 3.00–10.00 3.00–11.25
4.32 11.31 5.14 6.21 9.53
29.0 66.2 38.9 43.5 36.9
15.9 48.8 15.2 17.0 17.8
10.9–30.6 22.4–79.4 9.8–24.6 11.5–53.7 12.2–33.8
32.2 66.3 66.9 57.1 55.3
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Fig. 2. Linear regression plot of log10(saliva lead) versus log10(blood lead) for all
data. Pearson’s correlation coefﬁcient (r) = 0.457.
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also very similar for the three categories (standard deviation:
4.16 mg/dL, 3.72 mg/dL and 4.32 mg/dL, respectively). However,
the blood lead values for the “ﬂuctuating history” category were
much higher (mean: 17.62 mg/dL; median: 15.00 mg/dL). Vari-
ability was also much greater in this category (standard
deviation: 11.31 mg/dL).
For the saliva lead values, the mean and 75th percentile
values are substantially lower for history category 1 than for
categories 2 and 3 (mean: 19.8 mg/L, 27.8 mg/L and 29.0 mg/L,
respectively; 75th percentile: 23.8 mg/L, 29.1 mg/L and 30.6 mg/L,
respectively). The variability is also lower in category 1 than the
other two categories (standard deviation: 14.2 mg/L, 31.9 mg/L
and 32.2 mg/L respectively). However the median values do not
demonstrate any signiﬁcant difference (15.5 mg/L, 15.7 mg/L and
15.9 mg/L, respectively). Similarly to the results in blood, the
salivary lead values for the “ﬂuctuating history” category were
much higher (mean: 66.2 mg/L; median 48.8 mg/L). Variability
was also much higher (standard deviation: 66.3 mg/L) than for
categories 1, 2 or 3.
There were no substantial differences in the blood lead values
between smokers and non-smokers. For the saliva lead values, the
mean and 75th percentile values were higher (not statistically
signiﬁcant) in smokers than non-smokers (mean: 43.5 mg/L and
36.9 mg/L, respectively; 75th percentile 53.7 mg/L and 33.8 mg/L,
respectively). However, the median saliva lead values for smokers
and non-smokers were very similar (17.0 mg/L and 17.8 mg/L,
respectively), and variability was only very slightly higher (not
statistically signiﬁcant) in smokers than non-smokers (57.1 mg/L
and 55.3 mg/L, respectively).
3.3. Regression analysis
Fig. 2 shows log(saliva lead) plotted against log(blood lead) for
all of the 105 paired samples. A Pearson’s correlation coefﬁcient (r)
of 0.457 (95% C.I. 0.113–0.723; p = 0.0128) was observed betweenTable 3
Pearson’s correlation coefﬁcients (r) for log(saliva lead) with log(blood lead) for differe
All samples History of blood lead
Stability 1 S
Number of samples 105 27 4
Pearson’s correlation coefﬁcient (r) 0.457 0.473 
95% conﬁdence interval 0.291, 0.596 0.113, 0.723 
p-value <0.0001 0.0001 the two datasets. The correlations between log(saliva lead) and log
(blood lead) for the various history categories are shown in Table 3.
Only the “no history” category showed any substantial
difference in the r-value, with a much lower Pearson’s r (0.159,
C.I. 0.161 to 0.448) than the other categories. The correlations for
all other history categories were very similar, with no signiﬁcant
differences in Pearson’s r from one another, or from that of the
whole dataset.
Regression of log(saliva lead) and log(blood lead) on smoking
showed no evidence of any signiﬁcant effect due to smoking
(coefﬁcient 0.0446, p = 0.598 and coefﬁcient 0.0713,
p = 0.108 respectively). Regression of log(saliva lead) on age
showed no evidence of a signiﬁcant effect due to age (coefﬁcient
0.00577, p = 0.099); however there was evidence of an inverse
relationship between age and log(blood lead) (coefﬁcient 0.0128,
p = 0.000).
The correlations between log(saliva lead) and log(blood lead),
unadjusted and adjusted for smoking or for age (see Table 4a)
indicate that neither smoking nor age has a signiﬁcant effect on the
correlation between log(saliva lead) and log(blood lead). The
Pearson’s r values when adjusted for smoking status (r = 0.445
among smokers; r = 0.476 among non-smokers) or for age
(r = 0.474) all remain very similar to the unadjusted value
(r = 0.457). Regression of log(saliva lead) on log(blood lead),
adjusted for smoking status or for age (see Table 4b) conﬁrms
this – the coefﬁcients for smokers compared to non-smokers and
for age are both small and with high p-values, indicating that they
are not statistically signiﬁcant (coefﬁcient = 0.036, p = 0.632; and
coefﬁcient = 0.004, p = 0.153 respectively).
3.4. Additional testing of sampling devices
3.4.1. Blank saliva
The mean lead concentration and its standard deviation were
calculated for each blank saliva sample type. Sample types A
(refrigerated blank saliva, directly analysed) and B (frozen and
thawed blank saliva, directly analysed) both showed very low
blank results (0.238  0.063 mg/L and 0.376  0.130 mg/L respec-
tively), with the frozen saliva producing slightly higher results.
This difference was found to be signiﬁcant using a Student's t-test
(95% conﬁdence), and may have occurred due to the extra
preparation step in freezing and thawing the blank saliva.
Sample types C (refrigerated blank saliva, refrigerated in device)
and D (refrigerated blank saliva, frozen in device), which passed
through the StatSure device, showed much higher mean results
(3.512  1.352 mg/L and 2.861 1.128 mg/L, respectively) than A
and/or B. This indicates that a signiﬁcant amount of lead
contamination emanated from the device itself. This contamina-
tion was also highly variable, with the standard deviation for both
C and D approximately 40% of the mean. Although these levels of
contamination were small in comparison to the results obtained
from the occupationally-exposed lead workers participating in this
study; measurements of lower-level environmental exposures
could be over-estimated.
Using a Student’s t-test (95% conﬁdence), sample types C and D
were not found to differ signiﬁcantly from one another, indicatingnt history categories.
tability 2 Stability 3 Fluctuating history No history
2 44 21 40
0.494 0.531 0.498 0.159
0.224, 0.694 0.278, 0.715 0.085, 0.765 0.161, 0.448
0.0009 0.0002 0.0216 0.3276
Table 4a
Pearson’s correlation coefﬁcients (r) for log(saliva lead) with log(blood lead), unadjusted and adjusted for smoking status or for age.
Pearson’s r between log(saliva lead) and log (blood lead)
Unadjusted 0.457 (p < 0.0001)
Adjusted for smoking (yes/no) Smokers 0.445 (p = 0.0008)
Non-smokers 0.476 (p = 0.0004)
–
Adjusted for age (continuous variable) 0.474 (p < 0.0001)
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affect the blank result.
3.4.2. Comparison of device components
The mean and standard deviation were calculated for each blank
saliva sample type. The water samples from the outer tube showed
consistently low lead levels (mean: 0.027 mg/L; standard deviation
0.051 mg/L). The buffer solution showed slightly higher lead levels
(mean 0.293 mg/L; standard deviation 0.055 mg/L); however, they
were reasonably consistent, and at a low enough level to be of
minimal concern for the routine analysis of biological samples. The
paddle however, showed signiﬁcantly higher levels of lead
contamination, with a high degree of variability (mean 1.643mg/
L; standard deviation 0.661 mg/L). This contamination could reduce
the reliability of low-level environmental exposures using the
device.
4. Discussion
This study presents a sensitive method for the determination of
lead in saliva by ICP-MS. The LOD for this ICP-MS method was
extremely low (0.011 mg/L), allowing effective detection of lead at
trace levels. This is comparable to the sensitivity previously
achieved by Morton et al. (2014) (0.024 mg/L); and overcomes the
problems faced by researchers such as Wilhelm et al. (2002),
where a less sensitive method (LOD: 1.5 mg/L) led to a high
proportion of non-detects in the data. In this study, detectable lead
levels were found in all samples.
The lead levels detected in the saliva were lower than those
detected in blood, with the mean saliva lead value at 48.2% of the
mean blood lead value. As noted by Koh et al. (2003), the process of
saliva collection is inherently more prone to contamination than
that of obtaining a blood sample. It is possible that oral
contamination could have caused some of the highest saliva lead
measurements, and thereby skewed the mean saliva lead value
upwards. Therefore, a comparison of medians is perhaps more
valid–the median saliva lead value being 28.5% of the median blood
lead. The likelihood of oral contamination may have been reduced
by rinsing the mouth prior to sample collection; however, for this
sample collection, logistical constraints made it impracticable to
implement any further sampling procedures. Rinsing of the mouth
prior to sample collection may be beneﬁcial to reduce oral
contamination in future studies.
Previous studies have observed widely differing values of the
saliva lead: blood lead ratio, ranging from <1% (Barbosa et al.,
2006) up to 271% in P’an’s most highly-exposed subset (1981).Table 4b
Regression of log(saliva lead) on log(blood lead) adjusted for smoking status or for
age.
Coefﬁcient
Log(saliva lead) on log(blood lead) adjusted for smoking:
Coefﬁcient for log(blood lead) 0.533 (p < 0.001)
Coefﬁcient for smoker compared to non-smoker 0.036 (p = 0.632)
–
Log(saliva lead) on log(blood lead) adjusted for age:
Coefﬁcient for log(blood lead) 0.522 (p < 0.001)
Coefﬁcient for age 0.004 (p = 0.153)Although the very high values obtained by P’an may be explained
by the rapid increase in saliva lead levels at blood lead levels
>50 mg/L (Koh et al., 2003), there is still a great deal of unexplained
variation between studies in the literature. This is most likely due
to the lack of a standardised sample collection or preparation
method for the analysis of lead in saliva; the wide variety of
different procedures employed.
The method presented in this study, using a new sampling
device and a nitric acid digestion step to release protein-bound
lead in the matrix, obtained a mean blank-corrected recovery from
10 mg/L spiked saliva of 65.9% (SD: 1.83 mg/L, n = 13). This
demonstrates an improvement on the recovery of 30–35% reported
by Morton et al. (2014), where a comparable ICP-MS method was
used, but with a different sampling device and no acid-digestion
step. This may account for the higher levels of saliva lead observed
by this study than Morton et al. (2014) (median: 17.1 mg/L and
7.3 mg/L, respectively), despite the sample cohort reported in this
paper showing lower blood lead levels (median: 8.34 mg/dL and
20 mg/dL, respectively).
However, the StatSure device did exhibit a drawback – a
signiﬁcant level of lead contamination was shown to emanate from
the device, with a mean result from blank saliva of 2.86 mg/L (SD:
1.13 mg/L, n = 10) using the device, compared to 0.38 mg/L (SD:
0.36 mg/L, n = 10) by direct analysis, i.e. the device contributed
2.48 mg/L of lead to the saliva result. The results from blank saliva
aliquots sampled using the device also showed a higher degree of
variation than those analysed directly. An investigation of the lead
concentration of the device components showed that this
contamination originated in the sampling paddle. For this study
of occupationally-exposed lead workers, the median saliva lead
was 17.1 mg/L, and therefore the effect of this contamination would
be relatively small. However, this would be of concern for the
measurement of lower-level environmental exposures. The
manufacturers of the device have been made aware of the authors'
ﬁndings and will endeavour to ensure that this contamination is
not present in future batches. Additional analyses will be necessary
to conﬁrm this.
A weak but signiﬁcant correlation (r = 0.457) was observed
between the log(saliva lead) and log(blood lead) results from the
105 paired samples analysed. This is a stronger correlation than
that observed between the same variables by Barbosa et al. (2006)
(r = 0.277) or by Nriagu et al. (2006) (r = 0.156), and slightly stronger
than the correlation observed by Koh et al. (2003) between log
(saliva lead) and blood lead results (r = 0.41). A further study by
Thaweboon et al. (2005) reported a poor correlation between
saliva lead and blood lead. However, stronger correlations between
log(saliva lead) and log(blood lead) were observed in studies by
Morton et al. (2014) (r = 0.69) and by Pan AYS (1981) (r = 0.80).
The inconsistencies in the strength of the correlation between
blood and saliva measurements in these studies may perhaps be
explained by the degree of lead exposure received by the
participants, with higher lead exposures appearing to produce a
stronger correlation. The strongest correlation (r = 0.80) was found
in Pan AYS (1981), in which the majority of the individuals
concerned were highly occupationally exposed to lead, with a
mean blood lead value of 35.5 mg/dL. The studies by Morton et al.
(2014) and by Koh et al. (2003) also studied workers with
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20 mg/dL and 26.6 mg/L, respectively) and both produced signiﬁ-
cant correlations between blood and saliva lead (r = 0.69 and
0.41 respectively); whereas the studies by Barbosa et al. (2006),
that measured individuals with lower environmental exposures
(mean blood lead: 8.77 mg/dL) and by Nriagu et al. (2006), that
measured an unexposed population (mean blood lead: 2.7 mg/dL),
produced weaker correlations (r = 0.277 and 0.156 respectively).
This pattern was however contradicted by the Thaweboon et al.
(2005) study, which comprised 29 moderately-exposed individu-
als (geometric mean blood lead: 24.03 mg/dL) from a village in
which the water supply was contaminated due to lead mining, but
reported a poor correlation (Goodman–Kruskal g = 0.025).
Using a multiple regression model for log(saliva lead) on log
(blood lead), adjusted for smoking status and for age; neither term
was shown to have a statistically signiﬁcant effect on the
correlation (smoking status: p = 0.632, age: p = 0.153). These
ﬁndings are in agreement with previous work by
Morton et al. (2014) using a similar model (smoking status:
p = 0.451, age: p = 0.207). However, Nriagu et al. (2006) reported a
much stronger correlation in participants aged 46 and older
(r = 0.49), than in participants age 25 (r = 0.11) or age 26–45
(r = 0.15). This effect may be signiﬁcant at the low exposure levels
present in the unexposed population studied by Nriagu et al.
(2006), but insigniﬁcant in an occupationally-exposed population
with a higher degree of lead exposure. A further study could use
multiple regression to investigate the effects of smoking status and
age in an unexposed UK population.
The history of the individual's previous lead exposure was not
found to signiﬁcantly affect the correlation between log(blood
lead) and log(saliva lead). History categories 1 (D =  1 mg/dL), 2
(D =  2 mg/dL), 3 (D =  3 mg/dL) and “ﬂuctuating history” pro-
duced Pearson’s correlation coefﬁcients of r = 0.473
(C.I. 0.113–0.723), r = 0.494 (C.I. 0.224–0.694), r = 0.531 (C.I.
0.278–0.715) and r = 0.498 (C.I. 0.085–0.765), respectively. None
of these differ signiﬁcantly from one another, or from the value for
all samples of r = 0.457 (C.I. 0.291–0.596). At the time of writing, the
authors are unaware of any comparable studies that have taken
this factor into consideration.
The apparent increase in the strength of the correlation
between saliva lead and blood lead with increasing exposure, and
the fact that this correlation is unaffected by age or smoking
status, suggests that biological monitoring of salivary lead may be
useful as a non-invasive surrogate for blood lead, but only at high
exposure levels.
The kinetics of lead within the body are complex and not yet
entirely understood. Nriagu et al. (2006) found that the isotopic
ratios (208Pb/206Pb and 207Pb/206Pb) were almost identical in blood
and in saliva, suggesting that the lead content of saliva must be
derived from that in the bloodstream. Brodeur et al. (1983) showed
that blood and salivary lead respond differently during and after
lead exposure; moreover that salivary lead arises from the
diffusible fraction in the blood plasma, and that it reﬂects much
more recent exposure than blood lead. Therefore saliva lead
measurement may be useful in this context as a biomarker of
recent lead exposure – for example as a screening tool for workers
undergoing work such as demolition, which involves a risk of acute
exposure. However, before saliva lead measurement could be
utilised for the assessment of individuals; further work would
need to be carried out to understand how saliva lead levels respond
to exposure, and for how long after an exposure that the saliva lead
levels remain elevated. It may also be beneﬁcial to obtain data on
the variability of saliva lead measurements from the same worker,
by studying multiple repeat samples in quick succession.5. Conclusions
The ICP-MS method proposed by this study allows sensitive
determination of saliva lead with low detection limits and high
recovery. The StatSure sampling device is currently effective for
high occupational exposures, but contamination from the device
could confound measurements at lower environmental levels. The
correlation between saliva lead and blood lead was found to be
stronger at higher levels of exposure. In an occupationally-exposed
cohort, this correlation was not found to be signiﬁcantly affected by
age, smoking status or the history of the individual's previous lead
exposure. Further work could investigate the effects of these
factors at lower environmental exposure levels. Despite its
advantages as a non-invasive matrix, saliva lead measurement
could only be useful as a surrogate for blood lead for highly-
exposed populations. However, saliva lead may be useful in certain
applications as an alternative biomarker for recent lead exposure.
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